KDM5C and Huntington disease: These findings indicate that chromatin-remodeling enzymes, including SETDB1, PRMT5, Ezh2, JARID1C, may be potential therapeutic targets for HD treatment [131], further strengthening the observation that repressive neuronal chromatin mediated by histone methylation may have a crucial role in HD pathophysiology, including ND.